封面
市场调查报告书
商品编码
1721505

虾红素市场机会、成长动力、产业趋势分析及 2025 - 2034 年预测

Astaxanthin Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034

出版日期: | 出版商: Global Market Insights Inc. | 英文 263 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2024 年全球虾红素市场价值为 9.981 亿美元,预计到 2034 年将以 8.8% 的复合年增长率成长,达到 21.5 亿美元。虾红素是一种来自天然和合成来源的强效抗氧化剂,随着消费者对健康和保健意识的不断增强,它在各个行业中迅速发展。随着消费者越来越青睐天然、清洁标籤的产品,虾红素因其广泛的健康益处而成为首选成分。随着慢性生活方式疾病在年轻族群中变得越来越普遍,对预防性保健解决方案的需求也大幅增加。虾红素因其减少氧化压力和发炎的能力而闻名,越来越被认为是膳食补充剂和护肤配方中的关键成分。

虾红素市场 - IMG1

随着消费者寻求支持整体健康(包括皮肤、眼睛和心血管健康)的多功能成分,市场正在经历重大转变。健康习惯和功能性产品的日益普及,尤其是在千禧世代和 Z 世代中,推动了对天然虾红素的需求。製造商也注意到了这一趋势,透过提供可持续和环保的产品,这与人们对清洁美容、植物营养和环保生活的日益重视相一致。随着研究不断发现虾红素在医药、功能性食品甚至宠物营养方面的新应用,未来几年市场将实现强劲、持续的成长。

市场范围
起始年份 2024
预测年份 2025-2034
起始值 9.981亿美元
预测值 21.5亿美元
复合年增长率 8.8%

市场分为合成来源和天然来源,其中天然虾红素占据主导地位,到 2024 年市场规模达 6.332 亿美元。这种主导地位反映了消费者对植物性和天然成分的需求不断增长,因为注重健康的买家会避免合成添加剂。对清洁标籤产品的偏好提高了天然虾红素在补充剂、个人护理产品和强化食品中的使用。

虾红素广泛应用于膳食补充剂、药品、个人护理、食品和饮料以及动物饲料。光是膳食补充剂领域在 2024 年的估值就达到 3.156 亿美元,预计在 2025-2034 年期间的复合年增长率将达到 9.2%。这种增长源于消费者对富含抗氧化剂的补充剂的兴趣日益浓厚,这些补充剂可以促进免疫支持、皮肤健康和眼睛功能。在个人护理中,虾红素因其被证实具有中和自由基和增强皮肤弹性的能力而被广泛应用于抗衰老护肤品中。

2024 年,美国虾红素市场规模达到 7,740 万美元。随着消费者对天然抗氧化剂及其健康益处的认识不断提高,美国不断扩大的营养保健品、护肤品和功能性食品产业继续推动需求。

全球虾红素市场的主要参与者包括巴斯夫、Cardax、Algaecan Biotech、Cyanotech Corporation、富士化学工业有限公司、Divis Laboratories Limited、INNOBIO Limited、Lycored、昆明生物有限公司和Piveg, Inc. 这些公司正在积极投资高品质、可持续生产和战略合作伙伴关係,为广泛的行业提供创新、研发的虾红素解决方案。

目录

第一章:方法论与范围

第二章:执行摘要

第三章:行业洞察

  • 产业生态系统分析
    • 影响价值链的因素
    • 利润率分析
    • 中断
    • 未来展望
    • 製造商
    • 经销商
  • 供应商格局
  • 利润率分析
  • 重要新闻和倡议
  • 监管格局
  • 衝击力
    • 成长动力
      • 消费者对虾红素护肤品和药品的需求不断增长
      • 虾红素在全球烹饪应用中越来越受欢迎
      • 生态永续实践和清洁标籤趋势的成长
    • 产业陷阱与挑战
      • 虾红素产品製造的监管障碍
  • 成长潜力分析
  • 波特的分析
  • PESTEL分析

第四章:竞争格局

  • 介绍
  • 公司市占率分析
  • 竞争定位矩阵
  • 战略展望矩阵

第五章:市场估计与预测:按来源,2021 - 2034 年

  • 主要趋势
  • 合成的
  • 自然的

第六章:市场估计与预测:按应用,2021 - 2034 年

  • 主要趋势
  • 膳食补充剂
  • 个人护理
  • 製药
  • 食品和饮料
    • 功能性食品和饮料
    • 其他的
  • 动物饲料
    • 水产养殖
      • 鲑鱼
      • 鳟鱼
      • 其他的
    • 家畜
    • 宠物

第七章:市场估计与预测:按地区,2021 - 2034 年

  • 主要趋势
  • 北美洲
    • 我们
    • 加拿大
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 西班牙
    • 义大利
    • 俄罗斯
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 澳洲
    • 韩国
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中东和非洲
    • 沙乌地阿拉伯
    • 南非
    • 阿联酋

第八章:公司简介

  • Algaecan Biotech
  • BASF
  • Cardax
  • Cyanotech Corporation
  • Divis Laboratories Limited
  • Fuji Chemical Industries Company Limited
  • INNOBIO Limited
  • Kunming Biogenic Company Limited
  • Lycored
  • Piveg, Inc.
简介目录
Product Code: 202

The Global Astaxanthin Market was valued at USD 998.1 million in 2024 and is estimated to grow at a CAGR of 8.8% to reach USD 2.15 billion by 2034. Astaxanthin, a powerful antioxidant derived from both natural and synthetic sources, is rapidly gaining momentum across industries due to growing consumer awareness around health and wellness. As consumers shift their preferences toward natural, clean-label products, astaxanthin has emerged as a go-to ingredient for its wide-ranging health benefits. With chronic lifestyle diseases becoming more common among younger populations, demand for preventive health solutions has soared. Astaxanthin, known for its ability to reduce oxidative stress and inflammation, is increasingly recognized as a critical ingredient in both dietary supplements and skincare formulations.

Astaxanthin Market - IMG1

The market is witnessing a major shift as consumers seek multi-functional ingredients that support holistic health, including skin, eye, and cardiovascular wellness. The rising popularity of wellness routines and functional products, especially among millennials and Gen Z, is propelling the demand for natural astaxanthin. Manufacturers are also taking notice of this trend by offering sustainable and eco-friendly products, which align with the growing emphasis on clean beauty, plant-based nutrition, and environmentally conscious living. As research continues to uncover new applications of astaxanthin in pharmaceuticals, functional foods, and even pet nutrition, the market is poised for strong, sustained growth in the coming years.

Market Scope
Start Year2024
Forecast Year2025-2034
Start Value$998.1 Million
Forecast Value$2.15 Billion
CAGR8.8%

The market is segmented into synthetic and natural sources, with natural astaxanthin accounting for a dominant share of USD 633.2 million in 2024. This dominance reflects the increasing consumer demand for plant-based and naturally derived ingredients, as health-conscious buyers steer clear of synthetic additives. The preference for clean-label products has elevated the use of natural astaxanthin across supplements, personal care products, and fortified foods.

Astaxanthin finds broad application in dietary supplements, pharmaceuticals, personal care, food and beverages, and animal feed. The dietary supplements segment alone recorded a valuation of USD 315.6 million in 2024 and is set to grow at a 9.2% CAGR during 2025-2034. This growth stems from rising consumer interest in antioxidant-rich supplements that promote immune support, skin health, and eye function. In personal care, astaxanthin is widely adopted in anti-aging skincare due to its proven ability to neutralize free radicals and enhance skin elasticity.

The United States Astaxanthin Market reached USD 77.4 million in 2024. The country's expanding nutraceutical, skincare, and functional food sectors continue to drive demand, supported by growing consumer awareness about natural antioxidants and their health benefits.

Key players in the global astaxanthin market include BASF, Cardax, Algaecan Biotech, Cyanotech Corporation, Fuji Chemical Industries Company Limited, Divis Laboratories Limited, INNOBIO Limited, Lycored, Kunming Biogenic Company Limited, and Piveg, Inc. These companies are actively investing in R&D, sustainable production, and strategic partnerships to deliver innovative, high-quality astaxanthin solutions across a broad spectrum of industries.

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market scope and definition
  • 1.2 Base estimates and calculations
  • 1.3 Forecast calculation
  • 1.4 Data sources
    • 1.4.1 Primary
    • 1.4.2 Secondary
      • 1.4.2.1 Paid sources
      • 1.4.2.2 Public sources
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
    • 1.5.2 Data mining sources

Chapter 2 Executive Summary

  • 2.1 Industry synopsis, 2021-2034

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
    • 3.1.1 Factor affecting the value chain
    • 3.1.2 Profit margin analysis
    • 3.1.3 Disruptions
    • 3.1.4 Future outlook
    • 3.1.5 Manufacturers
    • 3.1.6 Distributors
  • 3.2 Supplier landscape
  • 3.3 Profit margin analysis
  • 3.4 Key news and initiatives
  • 3.5 Regulatory landscape
  • 3.6 Impact forces
    • 3.6.1 Growth drivers
      • 3.6.1.1 Rising consumer demand for astaxanthin-based skincare and pharmaceuticals
      • 3.6.1.2 Increasing popularity of astaxanthins in culinary applications globally
      • 3.6.1.3 Growth in eco-sustainable practices and clean-label trends
    • 3.6.2 Industry pitfalls and challenges
      • 3.6.2.1 Regulatory hurdles in astaxanthin product manufacturing
  • 3.7 Growth potential analysis
  • 3.8 Porter’s analysis
  • 3.9 PESTEL analysis

Chapter 4 Competitive Landscape, 2024

  • 4.1 Introduction
  • 4.2 Company market share analysis
  • 4.3 Competitive positioning matrix
  • 4.4 Strategic outlook matrix

Chapter 5 Market Estimates and Forecast, By Source, 2021 - 2034 (USD Million) (Kilo Tons)

  • 5.1 Key trends
  • 5.2 Synthetic
  • 5.3 Natural

Chapter 6 Market Estimates and Forecast, By Application, 2021 - 2034 (USD Million) (Kilo Tons)

  • 6.1 Key trends
  • 6.2 Dietary supplement
  • 6.3 Personal care
  • 6.4 Pharmaceuticals
  • 6.5 Food & beverages
    • 6.5.1 Functional food & beverages
    • 6.5.2 Others
  • 6.6 Animal feed
    • 6.6.1 Aquaculture
      • 6.6.1.1 Salmon
      • 6.6.1.2 Trout
      • 6.6.1.3 Shrimp
      • 6.6.1.4 Others
    • 6.6.2 Livestock
    • 6.6.3 Pets

Chapter 7 Market Estimates and Forecast, By Region, 2021 - 2034 (USD Million) (Kilo Tons)

  • 7.1 Key trends
  • 7.2 North America
    • 7.2.1 U.S.
    • 7.2.2 Canada
  • 7.3 Europe
    • 7.3.1 Germany
    • 7.3.2 UK
    • 7.3.3 France
    • 7.3.4 Spain
    • 7.3.5 Italy
    • 7.3.6 Russia
  • 7.4 Asia Pacific
    • 7.4.1 China
    • 7.4.2 India
    • 7.4.3 Japan
    • 7.4.4 Australia
    • 7.4.5 South Korea
  • 7.5 Latin America
    • 7.5.1 Brazil
    • 7.5.2 Mexico
    • 7.5.3 Argentina
  • 7.6 Middle East and Africa
    • 7.6.1 Saudi Arabia
    • 7.6.2 South Africa
    • 7.6.3 UAE

Chapter 8 Company Profiles

  • 8.1 Algaecan Biotech
  • 8.2 BASF
  • 8.3 Cardax
  • 8.4 Cyanotech Corporation
  • 8.5 Divis Laboratories Limited
  • 8.6 Fuji Chemical Industries Company Limited
  • 8.7 INNOBIO Limited
  • 8.8 Kunming Biogenic Company Limited
  • 8.9 Lycored
  • 8.10 Piveg, Inc.